Chronic Renal Failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Aged between 18 and 80 years, regardless of gender; 2.Diagnosed with end-stage renal disease due to chronic nephritis, diabetic nephropathy, or hypertensive nephropathy, with stable condition, receiving regular hemodialysis (2–3 times per week), and requiring regular HD+HP treatment (HP frequency =2 times per month); 3.Conscious, with good communication skills, able to understand and cooperate with the relevant procedures, examinations, and follow-ups of this study; 4.Voluntarily participating in this study and providing written informed consent signed by the participant or their legal guardian.
Exclusion criteria
Exclusion criteria: 1. Presence of severe cognitive impairment or a history of mental illness (such as schizophrenia or major depressive disorder) that would prevent cooperation with the study; 2. Comorbidities such as active bleeding, severe coagulation dysfunction, or a previous history of allergy to anticoagulants such as heparin; 3. Comorbidities such as malignant tumors, severe heart failure (NYHA Class IV), or severe arrhythmia, with an estimated survival period of less than 6 months or inability to tolerate HD+HP treatment; 4.Participation in other interventional clinical studies during the research period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coagulation Grading; | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment Efficiency ;Incidence of acute complications during treatment; | — |
Countries
China
Contacts
Pangang Group General Hospital